CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-16 | Yi Qingqing Director | Grant or award | +7,800 | 7,800 | ||
| 2021-06-16 | Yi Qingqing Director | Grant or award · Share Option (Right to Buy) | +17,498 | 17,498 | ||
| 2021-06-16 | OYLER JOHN Chief Executive Officer | Grant or award | +146,250 | 6,936,906 | ||
| 2021-06-16 | OYLER JOHN Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +906,906 | 906,906 | ||
| 2021-06-16 | Wang Xiaodong Director | Grant or award | +39,000 | 5,786,271 | ||
| 2021-06-16 | Wang Xiaodong Director | Grant or award · Share Option (Right to Buy) | +241,839 | 241,839 | ||
| 2021-06-16 | Wu Xiaobin President, COO & GM China | Grant or award | +78,000 | 1,213,729 | ||
| 2021-06-16 | Wu Xiaobin President, COO & GM China | Grant or award · Share Option (Right to Buy) | +483,678 | 483,678 | ||
| 2021-06-16 | Wang Lai Global Head of R&D | Grant or award | +53,625 | 238,654 | ||
| 2021-06-16 | Wang Lai Global Head of R&D | Grant or award · Share Option (Right to Buy) | +332,527 | 332,527 | ||
| 2021-06-16 | Huang Jane CMO, Hematology | Grant or award | +25,350 | 304,186 | ||
| 2021-06-16 | Huang Jane CMO, Hematology | Grant or award · Share Option (Right to Buy) | +157,196 | 157,196 | ||
| 2021-06-16 | Chen Timothy Yung-Cheng Director | Grant or award | +7,800 | 7,800 | ||
| 2021-06-16 | Chen Timothy Yung-Cheng Director | Grant or award · Share Option (Right to Buy) | +17,498 | 17,498 | ||
| 2021-06-16 | Glazer Donald W. Director | Grant or award | +7,800 | 2,754,529 | ||
| 2021-06-16 | Glazer Donald W. Director | Grant or award · Share Option (Right to Buy) | +17,498 | 17,498 | ||
| 2021-06-16 | HOOPER ANTHONY C Director | Grant or award | +7,800 | 7,800 | ||
| 2021-06-16 | HOOPER ANTHONY C Director | Grant or award · Share Option (Right to Buy) | +17,498 | 17,498 | ||
| 2021-06-16 | Malley Thomas Director | Grant or award | +7,800 | 17,082 | ||
| 2021-06-16 | Malley Thomas Director | Grant or award · Share Option (Right to Buy) | +17,498 | 17,498 |
Page 69 of 99 · 1,972 trades